» Articles » PMID: 34236594

Signaling Network Regulating Osteogenesis in Mesenchymal Stem Cells

Overview
Date 2021 Jul 8
PMID 34236594
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Osteogenesis is an important developmental event that results in bone formation. Bone forming cells or osteoblasts develop from mesenchymal stem cells (MSCs) through a highly controlled process regulated by several signaling pathways. The osteogenic lineage commitment of MSCs is controlled by cell-cell interactions, paracrine factors, mechanical signals, hormones, and cytokines present in their niche, which activate a plethora of signaling molecules belonging to bone morphogenetic proteins, Wnt, Hedgehog, and Notch signaling. These signaling pathways individually as well as in coordination with other signaling molecules, regulate the osteogenic lineage commitment of MSCs by activating several osteo-lineage specific transcription factors. Here, we discuss the key signaling pathways that regulate osteogenic differentiation of MSCs and the cross-talk between them during osteogenic differentiation. We also discuss how these signaling pathways can be modified for therapy for bone repair and regeneration.

Citing Articles

Signaling pathway mechanisms of circadian clock gene Bmal1 regulating bone and cartilage metabolism: a review.

Ze Y, Wu Y, Tan Z, Li R, Li R, Gao W Bone Res. 2025; 13(1):19.

PMID: 39870641 PMC: 11772753. DOI: 10.1038/s41413-025-00403-6.


Recent advances in the regulatory and non-coding RNA biology of osteogenic differentiation: biological functions and significance for bone healing.

Aranguren S, Cole H, Dargan L, Sarlo M, Choi S, Satapathy I Front Cell Dev Biol. 2025; 12():1483843.

PMID: 39834390 PMC: 11743950. DOI: 10.3389/fcell.2024.1483843.


The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy-Potential Implications in the Treatment of Osteogenesis Imperfecta.

Guo Q, Zhai Q, Ji P Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458939 PMC: 11510265. DOI: 10.3390/ph17101297.


The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?.

Younesi F, Hinz B Int J Mol Sci. 2024; 25(16).

PMID: 39201399 PMC: 11354465. DOI: 10.3390/ijms25168712.


Genetic deletion of ITIH5 leads to increased development of adipose tissue in mice.

Sessler T, Beier J, Villwock S, Jonigk D, Dahl E, Ruhl T Biol Res. 2024; 57(1):58.

PMID: 39198923 PMC: 11360682. DOI: 10.1186/s40659-024-00530-0.


References
1.
Askarinam A, James A, Zara J, Goyal R, Corselli M, Pan A . Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng Part A. 2013; 19(11-12):1386-97. PMC: 3638559. DOI: 10.1089/ten.TEA.2012.0367. View

2.
Fernandes H, Dechering K, van Someren E, Steeghs I, Apotheker M, Mentink A . Effect of chordin-like 1 on MC3T3-E1 and human mesenchymal stem cells. Cells Tissues Organs. 2010; 191(6):443-52. DOI: 10.1159/000281825. View

3.
Aihara K, Kuroda S, Kanayama N, Matsuyama S, Tanizawa K, Horie M . A neuron-specific EGF family protein, NELL2, promotes survival of neurons through mitogen-activated protein kinases. Brain Res Mol Brain Res. 2003; 116(1-2):86-93. DOI: 10.1016/s0169-328x(03)00256-0. View

4.
Kawashima N, Noda S, Yamamoto M, Okiji T . Properties of Dental Pulp-derived Mesenchymal Stem Cells and the Effects of Culture Conditions. J Endod. 2017; 43(9S):S31-S34. DOI: 10.1016/j.joen.2017.06.004. View

5.
Ann E, Kim H, Choi Y, Kim M, Mo J, Jung J . Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation. J Bone Miner Res. 2010; 26(2):317-30. DOI: 10.1002/jbmr.227. View